Latest PharmaceuticalMarket News and Updates : PharmaceuticalMarket updates, PharmaceuticalMarket News , PharmaceuticalMarket around the world

Nishadil

Washington | 20°C (light rain)

Viridian Therapeutics’ LUMVOA Gets FDA Nod, Poised for Market Debut

Top story

Viridian Therapeutics’ LUMVOA Gets FDA Nod, Poised for Market Debut

In focus

Latest feed

The Weight Loss Drug Revolution: Navigating a Fast-Evolving Market

Novo Nordisk Shares Rise After UK Greenlights First Daily GLP‑1 Weight‑Loss Pill, Healing Breach‑Related Wounds

Aurobindo Pharma Secures Landmark USFDA Approval for Generic Tofacitinib: A Game-Changer?

The Generic Drug Wars: TrumpRx Enters a Crowded Arena

Latest headlines

A Great Divide: American Biotech Grapples with the Ascendant Chinese Pharma Sector

A Great Divide: American Biotech Grapples with the Ascendant Chinese Pharma Sector

The Weight Loss Revolution: Novo Nordisk's CEO Declares We've Only Just Begun

The Weight Loss Revolution: Novo Nordisk's CEO Declares We've Only Just Begun

A Boost for Skin Health: Zydus Lifesciences Secures Key USFDA Approval

A Boost for Skin Health: Zydus Lifesciences Secures Key USFDA Approval

Waters Stock Takes a Hit After Strong Q4, Blames Murky 2024 Forecast

Waters Stock Takes a Hit After Strong Q4, Blames Murky 2024 Forecast

A Tale of Two Pivots: Hims & Hers Retreats on Weight-Loss Pill, Washington Post Sees Editorial Shift

A Tale of Two Pivots: Hims & Hers Retreats on Weight-Loss Pill, Washington Post Sees Editorial Shift

Hims & Hers Hits the Brakes: Generic Wegovy Plans Abandoned Amidst GLP-1 Market Shifts

Hims & Hers Hits the Brakes: Generic Wegovy Plans Abandoned Amidst GLP-1 Market Shifts

A New Era in Obesity Treatment: The Rise of Oral Weight-Loss Solutions

A New Era in Obesity Treatment: The Rise of Oral Weight-Loss Solutions

Ironwood Pharmaceuticals Shares Surge as Ambitious 2026 Outlook Ignites Investor Confidence

Ironwood Pharmaceuticals Shares Surge as Ambitious 2026 Outlook Ignites Investor Confidence

Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up

Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up

The Weight of Success: Unpacking Novo Nordisk’s Stranglehold on the GLP-1 Market

The Weight of Success: Unpacking Novo Nordisk’s Stranglehold on the GLP-1 Market

The Pharmaceutical Reckoning: How Weight Loss Breakthroughs Are Rewriting the Rules, One Pill (or Shot) at a Time

The Pharmaceutical Reckoning: How Weight Loss Breakthroughs Are Rewriting the Rules, One Pill (or Shot) at a Time

Unpacking Biopharma's Wild Ride: Fast Money's Hot Takes on Navigating the Next Wave

Unpacking Biopharma's Wild Ride: Fast Money's Hot Takes on Navigating the Next Wave

India's Weighty Dilemma: Lupin Pharma's Billion-Dollar Bet on Battling the Bulge

India's Weighty Dilemma: Lupin Pharma's Billion-Dollar Bet on Battling the Bulge

A New Chapter for Little Stomachs: Ironwood's Linzess Opens Doors for Pediatric IBS Relief

A New Chapter for Little Stomachs: Ironwood's Linzess Opens Doors for Pediatric IBS Relief

Rewriting the Rules: How Tiny Molecules Are Unlocking a Giant Future for Medicine

Rewriting the Rules: How Tiny Molecules Are Unlocking a Giant Future for Medicine

CAR-T's Tightrope Walk: Why Autolus Faces an Uphill Battle Despite a Breakthrough

CAR-T's Tightrope Walk: Why Autolus Faces an Uphill Battle Despite a Breakthrough

The Weight-Loss Gold Rush: Why All Eyes Are On Viking Therapeutics After a Hefty Biotech Deal

The Weight-Loss Gold Rush: Why All Eyes Are On Viking Therapeutics After a Hefty Biotech Deal

A New Frontier? Dr. Reddy's, The Weight Loss Revolution, And The Billions At Stake

A New Frontier? Dr. Reddy's, The Weight Loss Revolution, And The Billions At Stake

The Pharmaceutical Sector Set to Soar: A Path to $3.03 Trillion by 2034

The Pharmaceutical Sector Set to Soar: A Path to $3.03 Trillion by 2034

The Next Frontier: Eli Lilly and Novo Nordisk Gear Up for a Revolution in Oral Obesity Treatment

The Next Frontier: Eli Lilly and Novo Nordisk Gear Up for a Revolution in Oral Obesity Treatment

A New Chapter for Ophthalmology: Regeneron and Sandoz Resolve Landmark Eylea Patent Battle

A New Chapter for Ophthalmology: Regeneron and Sandoz Resolve Landmark Eylea Patent Battle

Amneal Pharmaceuticals Secures Landmark FDA Approval for Generic Risperdal Consta

Amneal Pharmaceuticals Secures Landmark FDA Approval for Generic Risperdal Consta

Global Leuprolide Acetate Market Poised for Significant Growth, Projected to Hit USD 4.43 Billion by 2032 as Hormone Therapy Demand Surges

Global Leuprolide Acetate Market Poised for Significant Growth, Projected to Hit USD 4.43 Billion by 2032 as Hormone Therapy Demand Surges

Lung Cancer Therapeutics Market Set to Soar Beyond $61 Billion by 2032: A New Horizon Driven by Precision Medicine and Immunotherapies

Lung Cancer Therapeutics Market Set to Soar Beyond $61 Billion by 2032: A New Horizon Driven by Precision Medicine and Immunotherapies

Antiemetics Drugs Market Set to Skyrocket to $11.69 Billion by 2032: A Deep Dive into Growth Drivers and Breakthrough Innovations

Antiemetics Drugs Market Set to Skyrocket to $11.69 Billion by 2032: A Deep Dive into Growth Drivers and Breakthrough Innovations

Fuelling Hope: Breakthroughs Propel Dementia Treatment Market Towards a Staggering $33.54 Billion Future

Fuelling Hope: Breakthroughs Propel Dementia Treatment Market Towards a Staggering $33.54 Billion Future

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?

The Autoimmune Revolution: IL-23 Inhibitors Poised for Massive Market Growth

The Autoimmune Revolution: IL-23 Inhibitors Poised for Massive Market Growth

Load more